- The trend backdrop is active with a 16-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
6586
TWO
Week ended 14 Aug 2026
Weekly Investor Report
CHO Pharma, Inc. · Healthcare · Biotechnology
Latest close
113.5 TWD
-5.8%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 78.0% above the Trend Line and sits at 72.2% of its 52-week range. The latest completed week returned -5.8%, after a -9.2% four-week move. Near-term considerations: volume confirmation is below normal.
Setup score
56
out of 100
Latest Close
113.5 TWD
14 Aug 2026
1W Return
-5.8%
latest completed week
4W Return
-9.2%
short-term follow-through
12W Return
62.6%
quarterly tape
Trend Breadth
30.8%
16 of 52 weeks active
Volume Ratio
0.4x
vs 13-week average
- The share remains more than 20% below its 52-week high.
- The latest week was a sharp negative move.
- Latest weekly return ranks in the weaker part of its sector group.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-5.8%
Latest completed week; four-week move -9.2%.
Indicator stack
62/61
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 78.0% above the Trend Line and sits at 72.2% of its 52-week range. The latest completed week returned -5.8%, after a -9.2% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.4x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
14 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.9812-week average 0.85
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.98Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -9.2% over four weeks, 62.6% over 12 weeks, and 196.7% over one year. The current trend has remained active for 16 consecutive weeks.
Performance by holding period
Active trend streak16 weeks
Active weeks in one year16
Trend breadth30.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.82Latest activity-pressure read.
Pressure change-48.6%Four-week change in activity pressure.
Leadership74.02Latest relative-leadership reading.
RS change-36.7%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment-
No current sentiment snapshot is stored.
Patient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-23.6%Distance below the 52-week high.
13-week volatility14.5%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
20 Mar
17 Apr
15 May
12 Jun
10 Jul
14 Aug
Weeks higher15 of 2611 weeks finished lower.
Best week+100.0%Week of 17 Apr.
Worst week-18.2%Week of 24 Apr.
Latest week-5.8%Week of 14 Aug.
Shape of recent returns
Strong gains9
Modest gains6
Flat weeks0
Modest losses6
Sharp losses5
Recent vol14.5%13-week weekly-return volatility.
Base vol16.5%52-week weekly-return volatility.
Up/down split21/30Count of positive and negative weeks in the 52-week window.
Average skew12.9% / -3.7%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorTW Healthcare
4-week rank88 / 100
Group average0.1%
Trend breadth34.0%
Trend34.0%active weekly trend signals
MD60.0%positive activity pressure
RS9.0%positive relative leadership
Four-week leaders
IndustryTW Biotechnology
4-week rank79 / 96
Group average-2.7%
Trend breadth24.0%
Trend24.0%active weekly trend signals
MD39.6%positive activity pressure
RS6.2%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape55/100
Trend, activity pressure, participation, and risk combine to a 55/100 tape read.
Indicator analysis91/100Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 12/12.
Activity pressure 0.98; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100No sentiment snapshot is stored yet.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 14 Aug 2026 | 113.5 TWD | -5.8% | 63.78 TWD | 56.19 TWD | 0.82 | 74.02 | 2.6M | On |
| 7 Aug 2026 | 120.5 TWD | 9.0% | 60.97 TWD | 55.93 TWD | 1.08 | 93.69 | 2.7M | On |
| 31 Jul 2026 | 110.5 TWD | -5.6% | 57.86 TWD | 55.65 TWD | 1.22 | 84.85 | 5.5M | On |
| 24 Jul 2026 | 117.0 TWD | -6.4% | 55.12 TWD | 55.47 TWD | 1.38 | 95.71 | 4.4M | On |
| 17 Jul 2026 | 125.0 TWD | 2.0% | 52.16 TWD | 55.23 TWD | 1.60 | 116.91 | 9.1M | On |
| 10 Jul 2026 | 122.5 TWD | -4.3% | 48.96 TWD | 54.97 TWD | 1.67 | 103.29 | 6.9M | On |
| 3 Jul 2026 | 128.0 TWD | 1.6% | 45.91 TWD | 54.74 TWD | 1.61 | 108.74 | 7.8M | On |
| 26 Jun 2026 | 126.0 TWD | 34.0% | 42.72 TWD | 54.48 TWD | 1.50 | 118.73 | 16.0M | On |
| 19 Jun 2026 | 94.00 TWD | 40.7% | 39.48 TWD | 54.18 TWD | 1.40 | 58.91 | 8.5M | On |
| 12 Jun 2026 | 66.80 TWD | 1.2% | 37.34 TWD | 54.10 TWD | 1.36 | 19.17 | 3.3M | On |
| 5 Jun 2026 | 66.00 TWD | -2.1% | 36.23 TWD | 54.24 TWD | 1.52 | 14.79 | 2.4M | On |
| 29 May 2026 | 67.40 TWD | -3.4% | 35.18 TWD | 54.39 TWD | 1.64 | 17.38 | 3.8M | On |
| 22 May 2026 | 69.80 TWD | 7.4% | 34.11 TWD | 54.50 TWD | 1.66 | 27.94 | 3.6M | On |
| 15 May 2026 | 65.00 TWD | 19.7% | 32.99 TWD | 54.54 TWD | 1.70 | 21.81 | 9.1M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.